0001140361-16-049561.txt : 20160201
0001140361-16-049561.hdr.sgml : 20160201
20160201165106
ACCESSION NUMBER: 0001140361-16-049561
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160128
FILED AS OF DATE: 20160201
DATE AS OF CHANGE: 20160201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBBINS LAWRENCE M
CENTRAL INDEX KEY: 0001228603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 161377927
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001138995
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 161377928
BUSINESS ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
BUSINESS PHONE: 2128124700
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
FORMER NAME:
FORMER CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT LLC
DATE OF NAME CHANGE: 20010420
4
1
doc1.xml
FORM 4
X0306
4
2016-01-28
0
0000070318
TENET HEALTHCARE CORP
THC
0001138995
GLENVIEW CAPITAL MANAGEMENT, LLC
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
1
0
1
0
0001228603
ROBBINS LAWRENCE M
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
0
0
1
0
Common Stock, $0.05 par value
2016-01-28
4
A
0
10698
0
A
10698
D
Common Stock, $0.05 par value
17890230
I
See footnotes 3 and 4
Represents restricted stock units ("RSUs") granted under the Issuer's Stock Incentive Plan to Mr. Ripperger and Mr. Simpson, two senior executives of Glenview Capital Management, LLC ("Glenview Capital Management"), in connection with their appointment to and service on the Issuer's Board of Directors (the "Board"). In accordance with the Director Compensation Policy of Glenview Capital Management, all income derived in connection with Mr. Ripperger's and Mr. Simpson's service as a director on the Company's Board belongs, in economic terms, to certain investment funds managed by Glenview Capital Management and neither Mr. Ripperger nor Mr. Simpson have any right to any compensation received in connection with their service on the Board. As such, neither Mr. Ripperger nor Mr. Simpson have any pecuniary interest in the RSUs reported herein.
Each RSU is the economic equivalent of one share of the Issuer's Common Stock, $0.05 par value per share (the "Shares"). All of these RSUs vested immediately on the grant date and will be settled in Shares as follows: (A) 2,542 RSUs will be settled in Shares within 60 days of Mr. Ripperger's termination of service from the Board; (B) 2,807 RSUs will be settled in Shares on the third anniversary of the date of grant to Mr. Ripperger; (C) 2,542 RSUs will be settled in Shares within 60 days of Mr. Simpson's termination of service from the Board; and (D) 2,807 RSUs will be settled in Shares on the third anniversary of the date of grant to Mr. Simpson.
These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management.
Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Each of Mr. Ripperger and Mr. Simpson serve on the Issuer's Board as a representative of Glenview Capital Management, LLC. By virtue of their representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Persons are deemed to be directors by deputization.
Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13D filed by the Reporting Persons on January 19, 2016 is incorporated herein by reference.
/s/ Mark J. Horowitz, President of Glenview Capital Management, LLC and Attorney-in-fact for Lawrence M. Robbins
2016-02-01